BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · IEX Real-Time Price · USD
1.150
-0.020 (-1.71%)
At close: Jul 26, 2024, 4:00 PM
1.170
+0.020 (1.74%)
After-hours: Jul 26, 2024, 6:37 PM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $43.16 million as of July 26, 2024. Its market cap has decreased by -86.99% in one year.
Market Cap
43.16M
Enterprise Value
71.00M
1-Year Change
-86.99%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $43.16M, a decrease of -74.25%. That is a compound annual growth rate of -19.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 43.90M | -49.19% |
Dec 29, 2023 | 86.40M | -85.65% |
Dec 30, 2022 | 601.90M | 5.82% |
Dec 31, 2021 | 568.80M | -49.48% |
Dec 31, 2020 | 1.13B | 327.25% |
Dec 31, 2019 | 263.50M | 336.26% |
Dec 31, 2018 | 60.40M | -63.96% |
Mar 8, 2018 | 167.60M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Longeveron | 46.64M |
VSee Lab/iDoc Virtual Telehealth Solutions, Inc. | 46.34M |
ARCA biopharma | 46.28M |
CalciMedica | 46.12M |
Carisma Therapeutics | 45.70M |
NextCure | 44.76M |
Bright Green | 44.52M |
Envoy Medical | 44.30M |